Back

Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: con

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Controversies in ventricular tachycardia ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Christian de Chillou

University Hospital of Nancy, Nancy (France)

5 More presentations in this session

Presentation thumbnail
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: pro
Professor T. Deneke (Nuremberg, DE)
Slides Video
Presentation thumbnail
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: discussion
Video
Presentation thumbnail
Ablation is alternative to ICD therapy post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: pro
Doctor P. Maury (Toulouse, FR)
Slides Video
Presentation thumbnail
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
Doctor A. Wijnmaalen (Leiden, NL)
Slides Video
Presentation thumbnail
Ablation is alternative to ICD therapy post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT: discussion
Video

Access the full session

Session thumbnail
Controversies in ventricular tachycardia ablation
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: pro
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: pro
thumbnail
Congress Presentation
Impact of preventive catheter ablation on heart failure outcomes in patients with ischemic cardiomyopathy and infarct-related coronary chronic total occlusion, insights from the PREVENTIVE VT trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources